The Supreme Court said the U.S. Department of Health and Human Services unlawfully cut lucrative pharmaceutical subsidies to some hospitals, in a victory for hospitals that had disputed the move.
The unanimous decision on Wednesday reverses two years of the cuts, which were made starting in 2018 as a centerpiece of the Trump administration’s health-policy agenda. The cuts sharply reduced federal subsidies under a program, known as 340B, created to help buoy hospitals that care for larger numbers of uninsured patients.
